A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

NCT03995901 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
15
Enrollment
INDUSTRY
Sponsor class

Stopped Talaris decided to discontinue living donor kidney transplant development program

Conditions

Interventions

Sponsor

Talaris Therapeutics Inc.